000 | 01721 a2200517 4500 | ||
---|---|---|---|
005 | 20250511185544.0 | ||
264 | 0 | _c19930211 | |
008 | 199302s 0 0 eng d | ||
022 | _a0391-4097 | ||
024 | 7 |
_a10.1007/BF03345810 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aProye, C | |
245 | 0 | 0 |
_aHigh incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. _h[electronic resource] |
260 |
_bJournal of endocrinological investigation _cOct 1992 |
||
300 |
_a651-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a3-Iodobenzylguanidine |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdiagnosis |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
650 | 0 | 4 |
_aCatecholamines _xbiosynthesis |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIodobenzenes _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aPheochromocytoma _xdiagnosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aVincristine _xtherapeutic use |
700 | 1 | _aVix, M | |
700 | 1 | _aGoropoulos, A | |
700 | 1 | _aKerlo, P | |
700 | 1 | _aLecomte-Houcke, M | |
773 | 0 |
_tJournal of endocrinological investigation _gvol. 15 _gno. 9 _gp. 651-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03345810 _zAvailable from publisher's website |
999 |
_c1485632 _d1485632 |